A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)

Autor:	Zhuang, Jieqin, Dai, Xingzhen, Jin, Zilin, Cai, Hairong, Wu, Qihua, Zhang, Weizhang, Gao, Huanjia, Chen, Bojun
Rok vydání:	2021
Předmět:	C The Control Group RR relative risk SARS SevereAcuteRespiratorySyndrom Traditional Chinese medicine Lianhua qingwen Other systems of medicine 0302 clinical medicine CNKI Chinese National Knowledge Infrastructure N Not clear FI Diagnosis and treatment of pneumonia caused by novel coronavirus infection (Trial version 5) 030212 general & internal medicine Clinical efficacy Medicine Chinese Traditional RCT randomized controlled trial SMD standard mean variance VIP Chinese Scientific Journal Database Clinical Trials as Topic FO Diagnosis and treatment of pneumonia caused by novel coronavirus infection (Trial version 4) COVID-19 corona virus disease 2019 Meta-analysis TCM traditional Chinese medicine Complementary and Manual Therapy China medicine.medical_specialty Coronavirus disease 2019 (COVID-19) 2019-nCoV 2019 novel Coronavirus Article 03 medical and health sciences CBM Chinese Biomedical Literature Database Internal medicine T The Treatment Group medicine Humans Critical condition Advanced and Specialized Nursing SARS-CoV-2 business.industry Significant difference COVID-19 PRISMA Preferred Reporting Items for Systematic Review and Meta-Analyses CI confidence interval Clinical trial Complementary and alternative medicine LQ Lianhua Qingwen Granules or Capsules Observational study CT Conventional Treatment business RZ201-999 030217 neurology & neurosurgery Drugs Chinese Herbal
Zdroj:	Complementary Therapies in Medicine, Vol 60, Iss, Pp 102754-(2021) Complementary Therapies in Medicine
ISSN:	0965-2299
Popis:	BACKGROUND: Traditional Chinese medicine (TCM) has been proven to played a great important role on the treatment of COVID-19. As one of the drugs recommended in Chinese guidelines, Lianhua Qingwen Granules or Capsules (LQ) are widely used.This systematic review and meta-analysis amis to evaluate the clinical efficacy of LQ on the treatment of COVID-19. METHODS: Seven databases (PubMed, EMBASE, CENTRAL, CNKI, VIP, CBM and Wanfang) were searched to include all appropriate clinical trials that explore the efficacy of LQ on the treatment of COVID-19. RESULT: A total of 3 trials including 245 COVID-19 patients were eventually enrolled.Compared with the control group,the LQ group showed great significant difference on reducing the rate of clinical change to severe or critical condition[RR = 0.38, 95 %CI (0.17,0.85), P 
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00b30ffab0d9d95b9565d1e2455a9f7 https://doi.org/10.1016/j.ctim.2021.102754 Zobrazit plný text záznamu Full Text from ScienceDirect